Trajenta
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Trajenta, covering 2017-09-11 to 2026-06-25. Get the full timeline:
Most recent: EMA Authorised: Trajenta (linagliptin) — Boehringer Ingelheim International GmbH